Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;8(1):e000515.
doi: 10.1136/lupus-2021-000515.

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study

Affiliations

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study

Isak Samuelsson et al. Lupus Sci Med. 2021 Jul.

Abstract

Objective: Patients with SLE have increased risk of myocardial infarction (MI). Few studies have investigated the characteristics of SLE-related MIs. We compared characteristics of and risk factors for MI between SLE patients with MI (MI-SLE), MI patients without SLE (MI-non-SLE) and SLE patients without MI (non-MI-SLE) to understand underlying mechanisms.

Methods: We identified patients with a first-time MI in the Karolinska SLE cohort. These patients were individually matched for age and gender with MI-non-SLE and non-MI-SLE controls in a ratio of 1:1:1. Retrospective medical file review was performed. Paired statistics were used as appropriate.

Results: Thirty-four MI-SLE patients (88% females) with a median age of 61 years were included. These patients had increased number of coronary arteries involved (p=0.04), and ≥50% coronary atherosclerosis/occlusion was numerically more common compared with MI-non-SLE controls (88% vs 66%; p=0.07). The left anterior descending artery was most commonly involved (73% vs 59%; p=0.11) and decreased (<50%) left ventricular ejection fraction occurred with similar frequency in MI-SLE and MI-non-SLE patients (45% vs 36%; p=0.79). Cardiovascular disease (44%, 5.9%, 12%; p<0.001) and coronary artery disease (32%, 2.9%, 0%; p<0.001), excluding MI, preceded MI/inclusion more commonly in MI-SLE than in MI-non-SLE and non-MI-SLE patients, respectively. MI-SLE patients had lower plasma albumin levels than non-MI-SLE patients (35 (29-37) vs 40 (37-42) g/L; p=0.002).

Conclusion: In the great majority of cases, MIs in SLE are associated with coronary atherosclerosis. Furthermore, MIs in SLE are commonly preceded by symptomatic vascular disease, calling for attentive surveillance of cardiovascular disease and its risk factors and early atheroprotective treatment.

Keywords: antiphospholipid syndrome; atherosclerosis; cardiovascular disease; inflammation; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet 2014;384:1878–88. 10.1016/S0140-6736(14)60128-8 - DOI - PubMed
    1. Rees F, Doherty M, Grainge MJ, et al. . Mortality in systemic lupus erythematosus in the United Kingdom 1999–2012. Rheumatology 2016;55:854–60. 10.1093/rheumatology/kev424 - DOI - PubMed
    1. Ingvarsson RF, Landgren AJ, Bengtsson AA, et al. . Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population. Lupus 2019;28:1488–94. 10.1177/0961203319877947 - DOI - PubMed
    1. Gustafsson JT, Simard JF, Gunnarsson I, et al. . Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther 2012;14:R46. 10.1186/ar3759 - DOI - PMC - PubMed
    1. Bernatsky S, Boivin J-F, Joseph L, et al. . Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7. 10.1002/art.21955 - DOI - PubMed

Publication types